DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,173,618 | -11.3% | 12,792 | -14.2% | 0.40% | -9.3% |
| Q2 2023 | $3,578,576 | -16.7% | 14,911 | -12.5% | 0.44% | -29.2% |
| Q1 2023 | $4,295,246 | -5.4% | 17,042 | -0.3% | 0.62% | -3.1% |
| Q4 2022 | $4,538,214 | +3.9% | 17,098 | +1.1% | 0.64% | -17.9% |
| Q3 2022 | $4,368,000 | -0.6% | 16,912 | -2.4% | 0.78% | +2.4% |
| Q2 2022 | $4,393,000 | -22.6% | 17,328 | -10.5% | 0.76% | +3.5% |
| Q1 2022 | $5,676,000 | -19.9% | 19,353 | -10.1% | 0.74% | -12.2% |
| Q4 2021 | $7,082,000 | +5.1% | 21,525 | -2.7% | 0.84% | -9.2% |
| Q3 2021 | $6,736,000 | +8.2% | 22,128 | -2.6% | 0.92% | +6.1% |
| Q2 2021 | $6,227,000 | +22.8% | 22,726 | +0.8% | 0.87% | +3.9% |
| Q1 2021 | $5,072,000 | +2.5% | 22,537 | +1.2% | 0.84% | -4.7% |
| Q4 2020 | $4,947,000 | +45.3% | 22,271 | +52.2% | 0.88% | +12.7% |
| Q3 2020 | $3,404,000 | +72.6% | 14,634 | +31.2% | 0.78% | +64.0% |
| Q2 2020 | $1,972,000 | +66.3% | 11,153 | +30.1% | 0.48% | +12.8% |
| Q1 2020 | $1,186,000 | – | 8,573 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |